Actively Recruiting

Age: 18Years +
All Genders
NCT06389721

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

Led by M.D. Anderson Cancer Center · Updated on 2026-04-24

45

Participants Needed

1

Research Sites

132 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cohort 1: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN). Cohort 2: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN) and to test a certain type of experimental neuromodulation (stimulation of the brain) with a device called a closed-loop brain-computer interface (clBCI) to see if can help to prevent pain due to CIPN.

CONDITIONS

Official Title

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to understand and read English, willing to sign informed consent, and follow study rules
  • ECOG Performance Status of 0 to 2
  • Willing to attend imaging sessions at MD Anderson
  • 18 years of age or older
  • Diagnosed with breast cancer
  • Receiving chemotherapy including doxorubicin, cyclophosphamide, docetaxel, or paclitaxel
  • Willing to participate in therapy sessions at home (for Objective 2 participants)
Not Eligible

You will not qualify if you...

  • Taking any antipsychotic medications
  • Having active central nervous system disease such as brain metastases, leptomeningeal disease, dementia, or encephalopathy
  • History of bipolar disorder or schizophrenia
  • Known peripheral neuropathy from causes other than chemotherapy
  • History of head injury or known seizure activity
  • Prior history of chemotherapy
  • Patients who will be given ddAC->T chemotherapy
  • Must remain on a stable medication course during chemotherapy if prescribed

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MD Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

L

Lorenzo Cohen, PHD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here